M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
FDA approves Wockhardt's prostate drug
1 October 2009 - Indian pharmaceutical and biotechnology company Wockhardt Ltd (BOM: 532300) said today that the US Food and Drug Administration (FDA) has approved its 10 mg extended release tablets of Alfuzosin Hydrochloride for the treatment of Benign Prostatic Hyperplasia (BPH or non-cancerous...If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search